| [English Session] [Vascular] | Apr. 19 (Fri.) 09:30-11:00 103 (1F) | |
|---|---|---|
| Vascular Aging and Cardiovascular Risk Assessment | ||
| Panel | Sung Ae Kim, Chi Young Shim, Eun Joo Cho | |
| 09:30-09:50 | Noninvasive Assessment of Arterial Stiffness: Recent Updates | Si Hyuck Kang / Seoul National Univ., Korea |
| 09:50-10:10 | Cardiovascular Risk Assessment in Asians: Challenges and Opportunities | Eugene Yang / Univ. of Washington, USA |
| 10:10-10:30 | Impact of Arterial Stiffness on Cardiac Function and Outcome | Hack Lyoung Kim / Seoul National Univ., Korea |
| 10:30-10:50 | Impact of Arterial Stiffness on Renal Function and Outcome | Chan Joo Lee / Yonsei Univ., Korea |
| 10:50-11:00 | Discussion | |
| [Myocardial Infarction 1] | Apr. 19 (Fri.) 09:30-11:00 106 (1F) | |
|---|---|---|
| Myocardial Infarction: What's New in AMI? | ||
| Chairperson(s) | 채성철, 정명호 | |
| Panel | 박종선, 배장환, 이장훈, 장기육, 황진용 | |
| 09:30-09:45 | A New Identifying and Classifying AMI; Case-Based Approach | 윤혁준 / 계명의대 |
| 09:45-10:00 | Optimizing DAPT Duration after AMI; Case-Based Approach | 박용휘 / 경상의대 |
| 10:00-10:15 | How to Limit Infarct Size in STEMI? | 강현재 / 서울의대 |
| 10:15-10:30 | Hemodynamic Support: Which Device for Which Patient and Why? | 장우진 / 이화의대 |
| 10:30-11:00 | Discussion | |
| [KSHF 1] | Apr. 19 (Fri.) 09:30-11:00 201 (2F) | |
|---|---|---|
| LVAD, 보험 급여 이후 현황과 전망 | ||
| Chairperson(s) | 전은석, 강석민 | |
| Panel | 김준성, 서석민, 염욱, 이선기, 홍석근 | |
| 09:30-09:45 | 보험 급여 이후 LVAD 현황 | 강혜영 / 건강보험심사평가원 |
| 09:45-10:00 | Indication of LVAD as BTT, BTC or DT: Cardiologist’s View: | 오재원 / 연세의대 |
| 10:00-10:15 | Perioperative Management of Patients with LVAD: Surgeon’s View: | 조양현 / 성균관의대 |
| 10:15-10:30 | Future Perspectives of LVAD in Korea | 최진오 / 성균관의대 |
| 10:30-11:00 | Discussion | |
| [BESCO] | Apr. 19 (Fri.) 09:30-11:00 203 (2F) | |
|---|---|---|
| 심혈관계 의료기기 기술개발 | ||
| Chairperson(s) | 이병권, 박철우 | |
| Panel | 안예찬, 유재영, 이계한, 이준상 | |
| 09:30-09:50 | Isolated Heart Model with the Mechanical Pumping System for Endoscopic Examination of Valve Motion | 김준홍 / 부산의대 |
| 09:50-10:10 | Next Generation Intravascular Optical Coherence Tomography in Clinical Practice | 하진용 / 세종대학교 |
| 10:10-10:30 | Recent Platelet Function Assays: Moving Microfluidics into Clinical Applications | 신세현 / 고려대학교 |
| 10:30-11:00 | Discussion | |
| [KHRS 1] | Apr. 19 (Fri.) 09:30-11:00 205 (2F) | |
|---|---|---|
| ECG Interpretation: A Case-Based Review | ||
| Chairperson(s) | 이명용, 황교승, 이경석, 장성원 | |
| 09:30-11:00 | ECG Review and Case Discussion | 박종성 / 동아의대, 안진희 / 부산의대, 신동금 / 한림의대, 정래영 / 전북의대, 김윤기 / 고려의대, 송인걸 / 건양의대, 천광진 / 강원의대, 유희태 / 연세의대, 현대우 / 안동병원, 곽혜빈 / 성균관의대 |
| [Hypertension] | Apr. 19 (Fri.) 11:10-12:40 103 (1F) | |
|---|---|---|
| Resistant Hypertension | ||
| Chairperson(s) | 조명찬, 박창규 | |
| Panel | 김원, 정우백, 조진만 | |
| 11:10-11:30 | How to Approach to Resistant Hypertension | 임상현 / 가톨릭의대 |
| 11:30-11:50 | How to Manage Resistant Hypertension | 신진호 / 한양의대 |
| 11:50-12:20 | Renal Nerve Denervation: Current and Future | 김병극 / 연세의대 |
| 12:20-12:40 | Discussion | |
| [Cross Specialty: Intervention & Heart Failure] | Apr. 19 (Fri.) 11:10-12:40 104 (1F) | |
|---|---|---|
| Ischemic Cardiomyopathy: Case-Based Debate & Discussion | ||
| Chairperson(s) | 유규형, 권현철 | |
| Panel | 김수중, 송영빈, 이상엽, 이혜원, 조재영, 최의영 | |
| 11:10-11:22 | Is This Patient Ischemic Cardiomyopathy? | 김계훈 / 전남의대 |
| 11:22-11:30 | Discussion | |
| 11:30-11:42 | How to Evaluate the Myocardial Ischemia/Viability? | 윤혁준 / 계명의대 |
| 11:42-11:50 | Discussion | |
| 11:50-12:02 | What Is the Optimal Medical Therapy? | 유병수 / 연세원주의대 |
| 12:02-12:10 | Discussion | |
| 12:10-12:22 | If Amenable, How to Revascularize? | 이주명 / 성균관의대 |
| 12:22-12:30 | Discussion | |
| 12:30-12:40 | Discussion | |
| [Adult Congenital Heart Disease 1] | Apr. 19 (Fri.) 11:10-12:40 106 (1F) | |
|---|---|---|
| Lifelong Issues of Valves - How to Save the Pulmonary and Aortic Valves | ||
| Chairperson(s) | 현명철, 배은정 | |
| Panel | 김중선, 박천수, 양지혁, 은영민, 장소익 | |
| 11:10-11:25 | Pulmonary Valve Disease in Adult | 조익성 / 중앙의대 |
| 11:25-11:40 | Pulmonary Valve Replacement for PS or PR with Surgery in CHD | 이철 / 가톨릭의대 |
| 11:40-11:55 | Pulmonary Valve Replacement for PS or PR with Transcatheter Intervention in CHD | 최재영 / 연세의대 |
| 11:55-12:10 | Bicuspid Aortic Valve | 박성지 / 성균관의대 |
| 12:10-12:25 | Aortic Valve Replacement with Transcatheter Intervention(TAVI) in Bicuspid Aortic Valve | 홍범기 / 연세의대 |
| 12:25-12:40 | Discussion | |
| [Women Heart Disease] | Apr. 19 (Fri.) 11:10-12:40 201 (2F) | |
|---|---|---|
| Valvular Heart Disease in Women | ||
| Chairperson(s) | 김명아, 홍경순 | |
| Panel | 김신재, 김학령, 설상훈, 윤현주 | |
| 11:10-11:30 | Gender Difference in Mitral Valve Disease | 손일석 / 경희의대 |
| 11:30-11:50 | Outcomes Following Valve Surgery | 정동섭 / 성균관의대 |
| 11:50-12:10 | TAVI and PMV | 장기육 / 가톨릭의대 |
| 12:10-12:30 | Management of Valvular Disease in Pregnancy | 박성미 / 고려의대 |
| 12:30-12:40 | Discussion | |
| [Cardiac Pathology] | Apr. 19 (Fri.) 11:10-12:40 203 (2F) | |
|---|---|---|
| 3D Modeling, 3D Printing, Virtual Reality and Real Hearts | ||
| Chairperson(s) | 김성호, 정해억 | |
| Panel | 배장환, 송진영, 이창하, 조구영 | |
| 11:10-11:25 | Cross the Border Between the Real and the Virtual! | 서정욱 / 서울의대 |
| 11:25-11:40 | The Limitation of 2D Imaging. Why Do We Need 3D Imaging and 3D Printing? | 윤연이 / 서울의대 |
| 11:40-11:55 | 3D Patient-Specific Digital Model from CT or MRI | 이활 / 서울의대 |
| 11:55-12:10 | Clinical Application of 3D Printing in Congenital Heart Disease | 송미경 / 서울의대 |
| 12:10-12:25 | 3D Printing Application in Cardiac Surgery | 윤태진 / 울산의대 |
| 12:25-12:40 | Discussion | |
| [English Session] [KHRS 2] | Apr. 19 (Fri.) 11:10-12:40 205 (2F) | |
|---|---|---|
| Stroke Summit: Stroke Prevention and Anticoagulation | ||
| Chairperson(s) | June Soo Kim, Kee-joon Choi, Dae-Kyeong Kim | |
| Panel | Dong Hyeok Kim, Myung Hwan Bae, Min Soo Ahn | |
| 11:10-11:18 | The Trend and Burden of Korean AF | Pil-Sung Yang / Cha Univ., Korea |
| 11:18-11:26 | LAA Occlusion: Present and Future | Seung Yong Shin / Chung-Ang Univ., Korea |
| 11:26-11:34 | Risk Stratification of Thromboembolism | Tae-Hoon Kim / Yonsei Univ., Korea |
| 11:34-11:42 | Imaging Modalities for AF Treatment | Jung Myung Lee / Kyunghee Univ., Korea |
| 11:42-11:50 | Korean Practical Guideline of NOAC Use | Jin Kyu Park / Hanyang Univ., Korea |
| 11:50-11:58 | Selection of NOAC | Myung-Jin Cha / Seoul National Univ., Korea |
| 11:58-12:06 | Use of NOAC in High Risk Bleeding Patients | Ki Hong Lee / Chonnam National Univ., Korea |
| 12:06-12:21 | Should OACs Be Prescribed for AF Patients with a CHA₂DS₂-VASc Score of 1 (Males) or 2 (Females)? | Tze-Fan Chao / Taipei Veterans General Hospital, Taiwan |
| 12:21-12:40 | Discussion | |
| Scientific Session [Boryung] | Apr. 19 (Fri.) 12:45-13:25 103 (1F) | |
|---|---|---|
| Recent Results in Clinical Trials of Fimasartan in Essential Hypertension | ||
| Chairperson(s) | 정명호, 채인호 | |
| 12:45-13:05 | Beneficial Effect of Fimasartan in HTN Patients | 박진주 / 서울의대 |
| 13:05-13:25 | How to Achieve BP Control? The Answer Is Fimasartan Based SPC! | 홍영준 / 전남의대 |
| Scientific Session [BMS/Pfizer] | Apr. 19 (Fri.) 12:45-13:25 104 (1F) | |
|---|---|---|
| Managing AF Patient with Concomitant ACS/undergoing PCI : The AUGUSTUS Trial | ||
| Chairperson(s) | 김준수, 김효수 | |
| 12:45-13:05 | Antithrombotic Therapy in Patients with NVAF Undergoing PCI : Should We Change Our Practice? | 강현재 / 서울의대 |
| 13:05-13:25 | AUGUSTUS Trial : An Open-label, 2 x 2 Factorial, Randomized Trial to Evaluate the Safety of Apixaban vs.VKA and Aspirin vs. Placebo in Patients with AF and ACS and/or PCI | Renato Delascio Lopes / Duke Univ., USA |
| Scientific Session [Samjin] | Apr. 19 (Fri.) 12:45-13:25 106 (1F) | |
|---|---|---|
| Prevention & Treatment for CardioMetabolic Syndrome | ||
| Chairperson(s) | 황교승, 구본권 | |
| 12:45-13:05 | Role of Clopidogrel in Coronary Artery Disease | 김수중 / 경희의대 |
| 13:05-13:25 | Stroke Prevention in Patients with Metabolic Syndrome and Atrial Fibrillation | 김진석 / 고려의대 |
| Scientific Session [MSD] | Apr. 19 (Fri.) 12:45-13:25 201 (2F) | |
|---|---|---|
| Protecting Patients with CVD in the Future | ||
| Chairperson(s) | 홍명기, 박헌식 | |
| 12:45-13:05 | The Benefit of Ezetimibe/atorvastantin Combination in Coronary Patients Treatment | 정영훈 / 경상의대 |
| 13:05-13:25 | New Treatment Option for SGLT2-Inhibitor in T2DM Patients-Ertugliflozin | 배장환 / 충북의대 |
| Scientific Session [Amgen] | Apr. 19 (Fri.) 12:45-13:25 203 (2F) | |
|---|---|---|
| PCSK9i (Evolocumab) : An Evolutionary Approach to Cardiovascular Therapeutics | ||
| Chairperson(s) | 정욱성, 김두일 | |
| 12:45-13:05 | The Positioning of PCSK9i in Updated Guidelines of Dyslipidemia | 김병진 / 성균관의대 |
| 13:05-13:25 | Clinical Evidence of Evolocumab and Its Practical Use | 홍순준 / 고려의대 |
| Diamond Session [Bayer] | Apr. 19 (Fri.) 12:45-13:25 205 (2F) | |
|---|---|---|
| Rivaroxaban, Decade of Consistency | ||
| Chairperson(s) | 이문형, 권현철 | |
| 12:45-13:05 | Consistent Safety Outcome of Rivaroxaban in NVAF Patients with Renal Impairment | 최종일 / 고려의대 |
| 13:05-13:25 | Safety Outcome of Rivaroxaban in AF Patient Undergoing PCI | 박경우 / 서울의대 |
| Break | Apr. 19 (Fri.) 13:25-13:40 ALL | |
|---|---|---|
| [English Session] [Memorial Lecture] | Apr. 19 (Fri.) 13:40-14:30 205 (2F) | |
|---|---|---|
| Chairperson(s) | Kee Sik Kim | |
| 13:40-14:00 | In Memory of Hi Myung Park | Shung Chull Chae / Kyungpook National Univ., Korea |
| 14:00-14:20 | Revascularization in Heart Failure: What We Now Know and Need to Still Learn | Eric Velaquez / Yale Univ.,USA |
| 14:20-14:30 | Discussion | |
| [KSE 1] | Apr. 19 (Fri.) 14:30-16:00 103 (1F) | |
|---|---|---|
| Valvular Heart Disease: Do We Really Know? | ||
| Chairperson(s) | 강덕현, 정해억 | |
| Panel | 박용현, 나진오 | |
| 14:30-14:50 | Multimodality Imaging in Aortic Stenosis: From Therapeutic Points of View | 윤연이 / 서울의대 |
| 14:50-15:10 | Asymptomatic Severe AS or Symptomatic Moderate AS: Early AVR or Watchful Waiting | 박성지 / 성균관의대 |
| 15:10-15:30 | Patient-prosthesis Mismatch: Is It Still Issue in the TAVR Era | 심지영 / 연세의대 |
| 15:30-15:50 | Secondary Tricuspid Regurgitation: Should It Be Treated and How? | 김형관 / 서울의대 |
| 15:50-16:00 | Discussion | |
| [KSIC 1] | Apr. 19 (Fri.) 14:30-16:00 104 (1F) | |
|---|---|---|
| Essence of Interventional Cardiology 2018 | ||
| Chairperson(s) | 안태훈, 정명호 | |
| Panel | 송영빈, 윤경호, 이상록, 이장훈, 임성훈, 정영훈, 한주용 | |
| 14:30-14:45 | Is Percutaneous Repair of Secondary Mitral Regurgitation Effective? | 강시혁 / 서울의대 |
| 14:45-15:00 | PCI Plus Medical Therapy Versus Medical Therapy Alone in Stable Coronary Artery Disease: Update from Recent Trials | 박덕우 / 울산의대 |
| 15:00-15:15 | Guide My Clinical Practice: 2018 Update of Clinical Outcomes in Currently Available 2nd Generation DES in Korea | 김민철 / 전남의대 |
| 15:15-15:30 | Are Paclitaxel Coated Devices Safe in Peripheral Artery Disease Intervention? | 노재형 / 충남의대 |
| 15:30-16:00 | Discussion | |
| [Myocardial Infarction 2] | Apr. 19 (Fri.) 14:30-16:00 106 (1F) | |
|---|---|---|
| Myocardial Infarction: Flash Debates in AMI | ||
| Chairperson(s) | 김종진, 차광수 | |
| Panel | 김동기, 윤재용, 조진만, 허승호, 허정호 | |
| 14:30-14:45 | Fibrinolytic Therapy Versus Primary PCI in STEMI | 심두선 / 전남의대 |
| 14:45-15:00 | Can Beta-Blockers Be Terminated Post-MI? - Who Really Needs Them and How Long? | 윤창환 / 서울의대 |
| 15:00-15:15 | PCI Strategy in Multi Vessel Disease: How and When? | 안성균 / 연세원주의대 |
| 15:15-15:30 | Challenges in AMI: Personalized Cardiology in the Very Elderly Population | 이상엽 / 충북의대 |
| 15:30-16:00 | Discussion | |
| [KSHF 2] | Apr. 19 (Fri.) 14:30-16:00 201 (2F) | |
|---|---|---|
| Essence of Recent HF Trials | ||
| Chairperson(s) | 유규형, 최동주 | |
| Panel | 김성해, 박성미, 박재형, 정진옥, 최의영, 한성우 | |
| 14:30-14:42 | PIONEER-HF | 김인철 / 계명의대 |
| 14:42-14:48 | Critique | 이상언 / 울산의대 |
| 14:48-15:00 | Discussion | |
| 15:00-15:12 | DECLARE-TIMI 58 | 윤종찬 / 한림의대 |
| 15:12-15:18 | Critique | 조상호 / 한림의대 |
| 15:18-15:30 | Discussion | |
| 15:30-15:42 | TRED-HF | 이주희 / 충북의대 |
| 15:42-15:48 | Critique | 조현재 / 서울의대 |
| 15:48-16:00 | Discussion | |
| [Basic Research 1] | Apr. 19 (Fri.) 14:30-16:00 203 (2F) | |
|---|---|---|
| Understanding Basics of Cardiovascular Research, Part I | ||
| Chairperson(s) | 안영근, 한진 | |
| Panel | 권기환, 김기석, 민필기, 이상학, 주형준, 홍순준 | |
| 14:30-14:50 | Use of Animal Models in Cardiovascular Research | 박훈준 / 가톨릭의대 |
| 14:50-15:10 | Non-coding RNAs in Vascular Calcification | 국현 / 전남의대 |
| 15:10-15:30 | The Past, Present, and Future of Adult Stem Cell Research | 권유욱 / 서울의대 |
| 15:30-16:00 | Discussion | |
| [KHRS 3] | Apr. 19 (Fri.) 14:30-16:00 205 (2F) | |
|---|---|---|
| AF Summit: Atrial Fibrillation | ||
| Chairperson(s) | 김대경, 김대혁 | |
| Panel | 김진석, 김태석, 박환철 | |
| 14:30-14:38 | What's New in Mechanism of Atrial Fibrillation | 최종일 / 고려의대 |
| 14:38-14:46 | AF Screening: EKG in Population >=65 years | 김진배 / 경희의대 |
| 14:46-14:54 | Pharmacologic Treatment of AF | 박예민 / 가천의대 |
| 14:54-15:02 | Optimal Ablation Strategy for Long Persistent Atrial Fibrillation. | 한성욱 / 계명의대 |
| 15:02-15:10 | New Techniques for Atrial Fibrillation Ablation | 임성일 / 고신의대 |
| 15:10-15:18 | Approach to Atrial Tachycardia After Atrial Fibrillation Ablation | 심재민 / 고려의대 |
| 15:18-15:26 | Ablation Is the First Line Treatment of AF: Pros | 박형욱 / 전남의대 |
| 15:26-15:34 | Ablation Is the First Line Treatment of AF: Cons | 최의근 / 서울의대 |
| 15:34-16:00 | Discussion | |
| [KSE 2] | Apr. 19 (Fri.) 16:10-17:40 103 (1F) | |
|---|---|---|
| Diastolic Dysfunction | ||
| Chairperson(s) | 김기식, 권준 | |
| Panel | 박태호, 정욱진 | |
| Are You Happy with ASE/EACVI Guidelines? | ||
| 16:10-16:30 | Absolutely No, Oldies but Goodies | 윤현주 / 전남의대 |
| 16:30-16:50 | Of Course, Yes, The New Is More Predictable | 김미정 / 가톨릭의대 |
| Heart Failure with Preserved EF | ||
| 16:50-17:10 | Should Be Described as a Diastolic Heart Failure | 박성미 / 고려의대 |
| 17:10-17:30 | Much More Comprehensive Meaning Beyond DHF | 윤종찬 / 한림의대 |
| 17:30-17:40 | Discussion | |
| [KSIC 2] | Apr. 19 (Fri.) 16:10-17:40 104 (1F) | |
|---|---|---|
| Disaster and Safety: How to Handle in the Cath. Lab. | ||
| Chairperson(s) | 장양수, 김효수 | |
| Panel | 김원, 이왕수, 조상호, 최성훈, 최윤석, 최철웅, 홍순준 | |
| 16:10-16:22 | Acute Vessel Closure: Now What? | 김웅 / 영남의대 |
| 16:22-16:34 | How to Treat Coronary Perforation | 원호연 / 중앙의대 |
| 16:34-16:46 | Stent Is Gone: Equipment Loss and/or Entrapment | 이진배 / 대구가톨릭의대 |
| 16:46-16:58 | How to Prevent Contrast Injury | 김제상 / 세종병원 |
| 16:58-17:10 | How to Prevent Radiation Injury for Patients&Staffs | 이상엽 / 충북의대 |
| 17:10-17:40 | Discussion | |
| [Adult Congenital Heart Disease 2] | Apr. 19 (Fri.) 16:10-17:40 106 (1F) | |
|---|---|---|
| Incidentally Diagnosed Congenital Heart Disease: How to Treat and Follow-Up | ||
| Chairperson(s) | 박승우, 송종민 | |
| Panel | 선병주, 송진영, 양동헌, 이미래 | |
| 16:10-16:25 | Atrial Septal Defect | 강이석 / 성균관의대 |
| 16:25-16:40 | Patent Ductus Arteriosus | 박혁진 / 전남의대 |
| 16:40-16:55 | Ventricular Septal Defect | 최정현 / 부산의대 |
| 16:55-17:10 | Anomalous Origin of Coronary Artery | 김형관 / 서울의대 |
| 17:10-17:25 | Persistent Foramen Ovale | 나진오 / 고려의대 |
| 17:25-17:40 | Discussion | |
| [Cardiac Surgery] | Apr. 19 (Fri.) 16:10-17:40 201 (2F) | |
|---|---|---|
| Understanding the Valve Surgeries for Cardiologists - Surgical Video Session | ||
| Chairperson(s) | 나찬영, 조광조 | |
| Panel | 김준성, 송승환, 신성호, 이해영, 홍준화 | |
| 16:10-16:25 | Cardiopulmonary Bypass Setup and Aortic Valve Replacement | 박표원 / 성균관의대 |
| 16:25-16:35 | Sutureless Aortic Valve Replacement | 김경환 / 서울의대 |
| 16:35-16:45 | Minimally Invasive Valve Surgery | 제형곤 / 부산의대 |
| 16:45-16:55 | Replacement of the Aortic Root (Bentall) | 주현철 / 연세의대 |
| 16:55-17:05 | Reimplantation of the Aortic Root (David) | 주석중 / 울산의대 |
| 17:05-17:15 | Totally Endoscopic Redo Mitral and Tricuspid Valve Surgery | 유재석 / 세종병원 |
| 17:15-17:40 | Discussion | |
| [Basic Research 2] | Apr. 19 (Fri.) 16:10-17:40 203 (2F) | |
|---|---|---|
| Understanding Basics of Cardiovascular Research, Part II | ||
| Chairperson(s) | 오구택, 최동훈 | |
| Panel | 기해진, 김용숙, 엄광현, 이찬주, 장우철, 허진 | |
| 16:10-16:30 | Practical Experience with Electrocardiography in Mouse | 최종일 / 고려의대 |
| 16:30-16:50 | Translational Research on Vaso-proliferative Retinopathy Using in Vivo Genome Editing | 김정훈 / 서울의대 |
| 16:50-17:10 | Understanding of Endothelial Mechanotransduction for Basic Researchers | 우창훈 / 영남의대 |
| 17:10-17:40 | Discussion | |
| [Ethics Workshop] | Apr. 19 (Fri.) 16:10-17:40 205 (2F) | |
|---|---|---|
| 늘어나는 의료분쟁과 의료현장에서 의료인폭행, 어떻게 이해할것인가? | ||
| Chairperson(s) | 김영대, 신동구 | |
| Panel | 김형윤, 심지영, 황경국 | |
| 16:10-16:30 | 의료분쟁의 현황과 원인 | 이동학 / 한국의료분쟁조정중재원 |
| 16:30-16:50 | 의료분쟁(사고)의 올바른 이해와 예방 | 윤태중 / 법무법인 태신 |
| 16:50-17:10 | 의료현장에서의 의료인에 대한 폭언과 폭행: 의료윤리적 대책 | 구영모 / 울산의대 |
| 17:10-17:30 | 임상윤리의 이해 | 권복규 / 이화의대 |
| 17:30-17:40 | Discussion | |
| [Imaging] | Apr. 20 (Sat.) 09:00-10:30 103 (1F) | |
|---|---|---|
| Imaging of Stable Coronary Artery Disease | ||
| Chairperson(s) | 송재관, 정정임 | |
| 09:00-09:20 | Diagnostic Approach of Stable Coronary Artery Disease | 안정민 / 울산의대 |
| 09:20-09:40 | Update of Cardiac CT for Stable Coronary Artery Disease | 전은주 / 서울의대 |
| 09:40-10:00 | CMR Perfusion and Viability | 장성아 / 성균관의대 |
| 10:00-10:20 | PET and Hybrid Imaging | 강원준 / 연세의대 |
| 10:20-10:30 | Discussion | |
| [KSIC 3] | Apr. 20 (Sat.) 09:00-10:30 104 (1F) | |
|---|---|---|
| Vascular Access: A To Z | ||
| Chairperson(s) | 한규록, 김두일 | |
| Panel | 강태수, 김상민, 도준형, 윤창환, 이봉기, 이장훈, 전국진 | |
| 09:00-09:12 | Vascular Access for Coronary Intervention - TFI, TRI, Distal Radial | 이준원 / 연세원주의대 |
| 09:12-09:24 | Vascular Access for Non-Coronary Intervention - TFI, TRI, Brachial, Others | 고충원 / 한림의대 |
| 09:24-09:36 | Hemostasis: A to Z | 허정호 / 고신의대 |
| 09:36-09:48 | How to Solve Access Site Problems | 유상용 / 울산의대 |
| 09:48-10:00 | Tips & Tricks of Vascular Access | 이재환 / 충남의대 |
| 10:00-10:30 | Discussion | |
| [KSoLA 1] | Apr. 20 (Sat.) 09:00-10:30 106 (1F) | |
|---|---|---|
| The Many Faces of SGLT2 Inhibitors : Are They Antidiabetic or Anti-CVDs? | ||
| Chairperson(s) | 김효수, 김성래 | |
| Panel | 김상용, 박형규, 양한모, 조상호, 현영율 | |
| 09:00-09:25 | Antidiabetic | 진상만 / 성균관의대 |
| 09:25-09:50 | Anti-CVDs | 이종영 / 성균관의대 |
| 09:50-10:30 | Discussion | |
| [KSCMS] | Apr. 20 (Sat.) 09:00-10:30 201 (2F) | |
|---|---|---|
| How to Control Cardiometabolic Risk Factors | ||
| Chairperson(s) | 김상현, 손일석 | |
| Panel | 박성미, 조경임, 한승환 | |
| 09:00-09:25 | Monitoring Strategies in Hypertensive Patients | 김학령 / 서울의대 |
| 09:25-09:50 | Controversies in the New Hypertension Guidelines - An Asian Perspective - | 임상현 / 가톨릭의대 |
| 09:50-10:15 | Socioeconomic Difference in the Management of Hypertension and Diabetes | 김현창 / 연세의대 |
| 10:15-10:30 | Panel Discussion | |
| [Smart Health] | Apr. 20 (Sat.) 09:00-10:30 203 (2F) | |
|---|---|---|
| Digital Cardiology Transformation | ||
| Chairperson(s) | 김용진, 김영학 | |
| Panel | 김형섭, 박경우, 배장환 | |
| 09:00-09:20 | Potential Application of Brain-Computer Interface for Communication and Rehabiliation | 임창환 / 한양대학교 |
| 09:20-09:40 | 노인 및 뇌졸중 환자의 보행 보조로봇 | 김연희 / 성균관의대 |
| 09:40-10:00 | Multicenter Atrial Fibrillation Registry Study Using Common Data Model | 조민수 / 울산의대 |
| 10:00-10:20 | Global Digital Healthcare Service Development | 김영인 / Noom코리아㈜ |
| 10:20-10:30 | Discussion | |
| [Cross Specialty: Arrhythmia & Heart Failure] | Apr. 20 (Sat.) 09:00-09:45 205 (2F) | |
|---|---|---|
| Debate 1: Primary Prevention ICDs in Patients with EF ≥ 35% | ||
| Chairperson(s) | 최동주, 오용석 | |
| Panel | 백용수, 유희태, 정욱진, 최성훈 | |
| 09:00-09:15 | Pro. | 박승정 / 성균관의대 |
| 09:15-09:30 | Con. | 박진주 / 서울의대 |
| 09:30-09:45 | Discussion | |
| [Cross Specialty: Arrhythmia & Heart Failure] | Apr. 20 (Sat.) 09:45-10:30 205 (2F) | |
|---|---|---|
| Debate 2: Atrial Fibrillation Ablation in Patients with Heart Failure | ||
| Chairperson(s) | 최동주, 오용석 | |
| Panel | 양동헌, 유승기, 이소령, 이영수 | |
| 09:45-10:00 | Pro. | 엄재선 / 연세의대 |
| 10:00-10:15 | Con. | 김인철 / 계명의대 |
| 10:15-10:30 | Discussion | |
| [Healthcare Policy] | Apr. 20 (Sat.) 10:40-12:10 103 (1F) | |
|---|---|---|
| 심장질환 급성기 치료 관련 전문인력 적정화 방안 | ||
| Chairperson(s) | 김기식, 김병옥 | |
| Panel | 배장환, 안철민, 조덕규 | |
| 10:40-10:55 | 전공의 수련특별법이 임상에 미치는 영향 | 장성인 / 연세의대 |
| 10:55-11:10 | 주 52시간 근로기준법 적용이 심혈관응급진료에 미치는 영향 | 문건웅 / 가톨릭의대 |
| 11:10-11:25 | Hospitalist, 의료인력 공백의 현실적 대안인가? | 김영삼 / 연세의대 |
| 11:25-12:10 | Discussion | |
| [Cross Specialty: Intervention & Imaging] | Apr. 20 (Sat.) 10:40-12:10 104 (1F) | |
|---|---|---|
| Beyond TAVR- Percutaneous Intervention in MV and TV | ||
| Chairperson(s) | 박승정, 최병욱 | |
| Panel | 고영국, 김주한, 김형관, 손일석, 용환석 | |
| 10:40-10:52 | Recent Update in TAVR 2019: Interventionist Perspective | 김효수 / 서울의대 |
| 10:52-11:04 | Recent Update in TAVR 2019: Imaging Specialist Perspective | 정정임 / 가톨릭의대 |
| 11:04-11:19 | Discussion | |
| 11:19-11:31 | Time to Start in Korea | 박덕우 / 울산의대 |
| 11:31-11:43 | ECHO Planning | 홍그루 / 연세의대 |
| 11:43-11:55 | CT Planning | 양동현 / 울산의대 |
| 11:55-12:10 | Discussion | |
| [KSoLA 2] | Apr. 20 (Sat.) 10:40-12:10 106 (1F) | |
|---|---|---|
| Aspirin for Primary Prevention of Cardiovascular Disease? | ||
| Chairperson(s) | 박중열, 이철환 | |
| Panel | 김용재, 김재택, 김학령, 조익성 | |
| 10:40-11:05 | Pros | 정영훈 / 경상의대 |
| 11:05-11:30 | Cons | 박경우 / 서울의대 |
| 11:30-12:10 | Discussion | |
| [English Session] [KSHF 3] | Apr. 20 (Sat.) 10:40-12:10 201 (2F) | |
|---|---|---|
| [English Session] Heart Failure and CAD | ||
| Chairperson(s) | Shung Chull Chae, Young-Kwon Kim | |
| Panel | Kye Hun Kim, Dae-Gyun Park, Sung-Ji Park, Chan Joo Lee, Seonghoon Choi, Kyung-Kuk Hwang | |
| 10:40-11:00 | How to Manage Ischemic MR | Eric Velaquez / Yale Univ.,USA |
| 11:00-11:15 | HFpEF and CAD | Seok-Jae Hwang / Gyeongsang National Univ., Korea |
| 11:15-11:30 | Surgical Treatment of Ischemic HF | Jae Suk Yoo / Sejong General Hospital, Korea |
| 11:30-11:45 | Multidisciplinary Approach to Manage Patients with Ischecmic HF | Eung Ju Kim / Korea Univ., Korea |
| 11:45-12:10 | Discussion | |
| [KPHS 1] | Apr. 20 (Sat.) 10:40-12:10 203 (2F) | |
|---|---|---|
| Imaging and Functional Assessment in CHD I | ||
| Chairperson(s) | 주찬웅, 이형두 | |
| Panel | 고훈, 권혜원, 박수진, 윤지홍, 최은영 | |
| 10:40-10:55 | Role of Myocardial Strain Imaging in Acyanotic CHD | 오진희 / 가톨릭의대 |
| 10:55-11:10 | Functional Assessment before and after VAD in Children | 정세용 / 연세의대 |
| 11:10-11:25 | How to Manage the Patients with Pulmonary Venous Obstruction in TAPVR : Pre-op & Post-op | 이상윤 / 서울의대 |
| 11:25-11:55 | Integrated Imaging Approach to Pulmonary Venous Obstruction | Shi-Joon Yoo / Univ. of Toronto, Canada |
| 11:55-12:10 | Discussion | |
| [KHRS 4] Essence series of arrhythmia | Apr. 20 (Sat.) 10:40-12:10 205 (2F) | |
|---|---|---|
| Essence Series of Arrhythmia | ||
| Chairperson(s) | 김유호, 조정관, 이만영, 신동구 | |
| Panel | 김성수, 노승영, 이지현, 이찬희 | |
| 10:40-10:53 | How to Apply Korean AF Guideline in Current Practice? | 정보영 / 연세의대 |
| 10:53-11:06 | How to Apply Korean Syncope Guideline in Current Practice? | 이영수 / 대구가톨릭의대 |
| 11:06-11:19 | How to Apply Korean VT Guideline in Current Practice? | 김주연 / 가톨릭의대 |
| 11:19-11:32 | How to Apply Device Guideline in Current Practice? | 박상원 / 세종병원 |
| 11:32-11:45 | New Techniques Not Available in Korean Patients: Remote Monitoring, SubQ ICD, Leadless Pacemaker, and His Bundle Pacing | 성정훈 / 차의대 |
| 11:45-12:10 | Discussion | |
| Scientific Session [Hanmi] | Apr. 20 (Sat.) 12:15-12:55 103 (1F) | |
|---|---|---|
| New Insight on Intensive Treatment for Hypertension and Dyslipidemia Management | ||
| Chairperson(s) | 박창규, 최동훈 | |
| 12:15-12:35 | Evidence-based Approach for Ideal Hypertension Management | 조구영 / 서울의대 |
| 12:35-12:55 | Advantages of Rosuvastatin and Ezetimibe Combination Treatment | 이무용 / 동국의대 |
| Scientific Session [Bayer] | Apr. 20 (Sat.) 12:15-12:55 104 (1F) | |
|---|---|---|
| Tailored Protection for Your Cardio-vascular Patients | ||
| Chairperson(s) | 김기식, 오용석 | |
| 12:15-12:35 | Consideration of Renal Outcome in Anticoagulation Treatment in NVAF Patients with Renal Impairment | 임홍의 / 한림의대 |
| 12:35-12:55 | New Antithrombotic Treatment Strategies in Patients with Chronic CAD and PAD | 김병극 / 연세의대 |
| Scientific Session [Takeda/Dong-A ST] | Apr. 20 (Sat.) 12:15-12:55 106 (1F) | |
|---|---|---|
| The Way to Improve BP Control Rate | ||
| Chairperson(s) | 김철호, 조명찬 | |
| 12:15-12:35 | Differential Benefits and Real World Clinical Practices of Azilsartan Medoxomil | 홍그루 / 연세의대 |
| 12:35-12:55 | The 1st APC, Azilsartan Medoxomil/Chlorthalidone for Uncontrolled Hypertensive Patients | 김용진 / 서울의대 |
| Scientific Session [Novartis] | Apr. 20 (Sat.) 12:15-12:55 201 (2F) | |
|---|---|---|
| ARNI : PIONEER HF for Hospitalized Patients | ||
| Chairperson(s) | 전은석, 최동주 | |
| 12:15-12:55 | PIONEER-HF : Prime Time for ARNI in Stabilized AHF Patients | Eric Velaquez / Yale Univ.,USA |
| Scientific Session [Daiichisankyo/ Daewoong] | Apr. 20 (Sat.) 12:15-12:55 203 (2F) | |
|---|---|---|
| Achieving Best Outcomes for Patients with Cardiovascular Disease with Edoxaban and Olmesartan | ||
| Chairperson(s) | 강석민, 편욱범 | |
| 12:15-12:35 | Translating RWE: Validating Safety and Effetiveness of NOACs in Clinical Tractice | 최의근 / 서울의대 |
| 12:35-12:55 | New Strategies to Improve Treatment Adherence in Hypertension | 성지동 / 성균관의대 |
| Diamond Session [BMS/Pfizer] | Apr. 20 (Sat.) 12:15-12:55 205 (2F) | |
|---|---|---|
| Leading Excellence for Stroke Prevention in NVAF | ||
| Chairperson(s) | 한성욱, 정보영 | |
| 12:15-12:35 | AUGUSTUS Trial : What Is the Optimal Antithrombotic Strategy for AF Patient Who Develop ACS | Renato Delascio Lopes / Duke Univ., USA |
| 12:35-12:55 | Anticoagulation in AF with Comorbidities: “Fragile Patient” | 배명환 / 경북의대 |
| Scientific Session [Pfizer] | Apr. 20 (Sat.) 12:15-12:55 211 (2F) | |
|---|---|---|
| Strategies to Optimize Management of CVD | ||
| Chairperson(s) | 김영대 | |
| 12:15-12:35 | Highlighting 20 Years of CV Protection with Atorvastatin : Focusing on Secondary Prevention | 남창욱 / 계명의대 |
| 12:35-12:55 | Blood Pressure Variability : Its Prognostic Significance in CV Disease | 손일석 / 경희의대 |
| Break | Apr. 20 (Sat.) 12:55-13:10 ALL | |
|---|---|---|
| [KSE 3] | Apr. 20 (Sat.) 13:10-14:40 103 (1F) | |
|---|---|---|
| Essence Session in Echocardiography and Valvular Heart Disease | ||
| Chairperson(s) | 송재관, 박승우 | |
| Panel | 송종민, 조구영 | |
| 13:10-13:30 | Right Ventricular Strain: Measurement and Clinical Application | 박재형 / 충남의대 |
| 13:30-13:50 | Deep Learning for Predicting Outcome in Heart Disease | 권준명 / 세종병원 |
| 13:50-14:10 | Atriogenic Mitral Regurgitation: New Mechanism of Functional MR | 김대희 / 울산의대 |
| 14:10-14:30 | Echo Guidance for Intervention in Valvular Heart Disease | 홍그루 / 연세의대 |
| 14:30-14:40 | Discussion | |
| [KSIC 4] | Apr. 20 (Sat.) 13:10-14:40 104 (1F) | |
|---|---|---|
| Debates in Medical Treatments Other than Antithrombotic Treatment after PCI | ||
| Chairperson(s) | 윤정한, 채인호 | |
| Panel | 김원, 김중선, 남창욱, 양태현, 우종신, 홍영준 | |
| 13:10-13:22 | Statin: High Dose Statin vs. Ezetimibe Combination? | 김병극 / 연세의대 |
| 13:22-13:34 | Beta Blocker after AMI: How Much, How Long, Which Drug, and in Which Patients? | 박진주 / 서울의대 |
| 13:34-13:46 | RAS Inhibitors: In Every Patients or Only in Hypertensive Patients? | 박근호 / 조선의대 |
| 13:46-13:58 | Antihyperglycemic Agents: Which Drugs and How Intensive? | 정영훈 / 경상의대 |
| 13:58-14:10 | Antianginal Medications: Which Drugs and in Which Patients? | 배장환 / 충북의대 |
| 14:10-14:40 | Discussion | |
| [KSoLA 3] | Apr. 20 (Sat.) 13:10-14:40 106 (1F) | |
|---|---|---|
| The Truth About Omega-3: Is It Really a 'Good Fat'? | ||
| Chairperson(s) | 이문규, 백상홍 | |
| Panel | 김은미, 박훈준, 조재형, 황유철 | |
| 13:10-13:35 | Pros | 이상학 / 연세의대 |
| 13:35-14:00 | Cons | 박정현 / 인제의대 |
| 14:00-14:40 | Discussion | |
| [KSHF 4] | Apr. 20 (Sat.) 13:10-14:40 201 (2F) | |
|---|---|---|
| Cardiac Critical Care: | ||
| Chairperson(s) | 조명찬, 김명아 | |
| Panel | 박상민, 유승기, 이수용, 장세용, 정혜문, 최정현 | |
| 13:10-13:25 | Discontinuation of CRRT in Cardiorenal Syndrome | 이정환 / 서울의대 |
| 13:25-13:40 | Left Ventricular Unloading in Patients with Cardiogenic Shock | 박택규 / 성균관의대 |
| 13:40-13:55 | Management of Respiratory Failure in Heart Failure Patients | 김영삼 / 연세의대 |
| 13:55-14:10 | What Is the Optimal Vasopressors in Various Situations of HF? | 김민석 / 울산의대 |
| 14:10-14:40 | Discussion | |
| [KPHS 2] | Apr. 20 (Sat.) 13:10-14:40 203 (2F) | |
|---|---|---|
| Now and the Future in Pediatric Cardiology | ||
| Chairperson(s) | 김성호, 김영휘 | |
| Panel | 공영화, 이철, 장기영, 최창휴 | |
| 13:10-13:25 | The Current Burden of Pediatric Heart Disease Including CHD | 이재영 / 가톨릭의대 |
| 13:25-13:40 | General Approach to Diagnosis and Treatment for Children's Arrhythmia | 허준 / 성균관의대 |
| 13:40-13:55 | Device, All the Past to the Present, and the Future Direction | 김성호 / 세종병원 |
| 13:55-14:05 | Insurance Issues in Care of CHD | 하기수 / 고려의대 |
| 14:05-14:25 | My Methods in Congenital Heart Disease Surgery | 성시찬 / 부산의대 |
| 14:25-14:40 | Discussion | |
| [KHRS 5] | Apr. 20 (Sat.) 13:10-14:40 205 (2F) | |
|---|---|---|
| PSVT and VT | ||
| Chairperson(s) | 남기병, 이문형, 오용석, 배은정 | |
| Panel | 권창희, 김민수, 반지은, 이혜영, 장진근 | |
| 13:10-13:18 | Pacing Maneuvers for SVT Differentiation | 김성환 / 가톨릭의대 |
| 13:18-13:26 | Treatment of PSVT | 박준범 / 이화의대 |
| 13:26-13:34 | How I Overcame a Challenging Case of PSVT? | 오세일 / 서울의대 |
| 13:34-13:42 | ECG Localization: Outflow VT | 진은선 / 경희의대 |
| 13:42-13:50 | ECG Localization: Non-Outflow VT | 온영근 / 성균관의대 |
| 13:50-13:58 | Pharmacologic Treatment of VT | 김유리 / 동국의대 |
| 13:58-14:06 | Neuromodulation in Refractory Ventricular Arrhythmia | 박경민 / 성균관의대 |
| 14:06-14:14 | New Technique and Technologies in VT Ablation | 김준 / 울산의대 |
| 14:14-14:40 | Discussion | |
| [KSE 4] | Apr. 20 (Sat.) 14:50-16:20 103 (1F) | |
|---|---|---|
| Imaging and Heart Failure | ||
| Chairperson(s) | 임세중, 조은주 | |
| Panel | 김형섭, 설상훈 | |
| 14:50-15:10 | What Is the Best Prognosticator in HF?: Imaging vs. Biomarker | 최정현 / 부산의대 |
| 15:10-15:30 | Cardiac Cath Will Guide the Course and Management for HF | 이주희 / 충북의대 |
| 15:30-15:50 | Imaging in Athletes: How to Differentiate with Pathology? | 선병주 / 충남의대 |
| 15:50-16:10 | How to Use Cardiac Imaging for Therapeutic Guideline in HF | 양동헌 / 경북의대 |
| 16:10-16:20 | Discussion | |
| [KSIC 5-1] | Apr. 20 (Sat.) 14:50-15:35 104 (1F) | |
|---|---|---|
| Debate in Interventional Cardiology | ||
| Chairperson(s) | 김종진, 박창규 | |
| Panel | 강웅철, 김주한, 김학령, 이병권, 이왕수, 조진만, 최철웅 | |
| Renal Denervation in Resistant Hypertension: Something, Nothing Or Everything?! | ||
| 14:50-15:05 | Pros | 최승혁 / 성균관의대 |
| 15:05-15:20 | Cons | 신진호 / 한양의대 |
| 15:20-15:35 | Discussion | |
| [KSIC 5-2] | Apr. 20 (Sat.) 15:35-16:20 104 (1F) | |
|---|---|---|
| Debate in Interventional Cardiology | ||
| Chairperson(s) | 홍명기, 장병철 | |
| Panel | 공준혁, 김준범, 김준홍, 나승운, 박근호, 장기육 | |
| TAVR in Low Risk Patient: Light on the Horizon? | ||
| 15:35-15:50 | Interventionist's View | 고영국 / 연세의대 |
| 15:50-16:05 | Surgeon's View | 황호영 / 서울의대 |
| 16:05-16:20 | Discussion | |
| [KSoLA 4] Essence Session | Apr. 20 (Sat.) 14:50-16:20 106 (1F) | |
|---|---|---|
| The Debate on New Lipid Guidelines | ||
| Chairperson(s) | 박경수, 한기훈 | |
| Panel | 김범준, 박재형, 윤창환, 이병완, 조홍근 | |
| 14:50-15:15 | KSoLA Guideline | 정인경 / 경희의대 |
| 15:15-15:40 | 2018 ACC/AHA Guideline | 김상현 / 서울의대 |
| 15:40-16:20 | Discussion | |
| [Epidemiology] | Apr. 20 (Sat.) 14:50-16:20 201 (2F) | |
|---|---|---|
| Novel Biomarkers and Risk Factors for Heart Disease | ||
| Chairperson(s) | 김광일, 김현창 | |
| Panel | 배장환, 손일석, 정선재 | |
| 14:50-15:00 | Systems Epidemiology Approach for Better CVD Prevention | 김현창 / 연세의대 |
| 15:00-15:15 | Stress Biomarkers and Cardiovascular Disease | 이주미 / 을지의대 |
| 15:15-15:30 | Immunosenescence & Inflammaing Biomarkers and Cardiovascular Disease | 이원우 / 서울의대 |
| 15:30-15:45 | Mebabolomics Approach to Biomarkers and Mechanisms of Cardiometabolic Disease | 이상국 / 연세의대 |
| 15:45-16:00 | Social Network Analysis and Cardiovascular Disease | 염유식 / 연세대학교 |
| 16:00-16:20 | Discussion | |
| [English Session] [KPHS 3] | Apr. 20 (Sat.) 14:50-16:20 203 (2F) | |
|---|---|---|
| Comprehensive Management of Perioperative CHD | ||
| Chairperson(s) | Nam Su Kim, Young Hwan Park | |
| Panel | Ji Hee Kwak, Mi-Kyoung Song, Yu Rim Shin, Ja Kyung Yoon | |
| 14:50-15:05 | What Is the Most Important Point Surgeons Need before Cyanotic CHD Surgery? | Hyungtae Kim / Pusan National Univ., Korea |
| 15:05-15:20 | Myocardial Protection for CHD in Anesthesia Perspective | Jong Wook Song / Yonsei Univ., Korea |
| 15:20-15:35 | Current Strategy for Cardio-Pulmonary Bypass in Neonates | Sungkyu Cho / Seoul National Univ., Korea |
| 15:35-15:50 | Perioperative Cardiac Surgery Management in TOF | Chun Soo Park / Ulsan Univ., Korea |
| 15:50-16:05 | Physiology of Pulmonary Regurgitation after TOF Repair: New Insights from MRI | Shi-Joon Yoo / Univ. of Toronto, Canada |
| 16:05-16:20 | Discussion | |
| [KHRS 6] | Apr. 20 (Sat.) 14:50-16:20 205 (2F) | |
|---|---|---|
| CIED and Sudden Cardiac Death | ||
| Chairperson(s) | 오동진, 정병천, 김남호, 곽충환 | |
| Panel | 남궁준, 신승용, 이광노, 임우현 | |
| 14:50-14:58 | What Should We Know for ICD Therapy? | 고점석 / 원광의대 |
| 14:58-15:06 | What Should We Know for CRT Therapy? | 오일영 / 서울의대 |
| 15:06-15:14 | Update on Risk Stratification for SCD in Heart Failure | 한상진 / 한림의대 |
| 15:14-15:22 | What Should We Know for SCD Management? | 이대인 / 충북의대 |
| 15:22-15:30 | ICD Troubleshooting: Shock Reduction Strategy | 김동민 / 단국의대 |
| 15:30-15:38 | Prevention and Management of CIED Infection | 박형섭 / 계명의대 |
| 15:38-15:46 | Update in J Wave Syndrome | 윤남식 / 전남의대 |
| 15:46-15:54 | Substrate and Risk Stratification in Cardiomyopathies | 조용근 / 경북의대 |
| 15:54-16:20 | Discussion | |